Shaker O - Search Results

1

Human leukocyte antigen class II alleles (DQB1 and DRB1) as predictors for response to interferon therapy in HCV genotype 4.

Shaker O, Bassiony H, El Raziky M, El-Kamary SS, Esmat G, El-Ghor AM, Mohamed MM. Shaker O, et al. Mediators Inflamm. 2013;2013:392746. doi: 10.1155/2013/392746. Epub 2013 Mar 14. Mediators Inflamm. 2013. PMID: 23576852 Free PMC article.

2

Changing patterns of acute viral hepatitis at a major urban referral center in Egypt.

Zakaria S, Fouad R, Shaker O, Zaki S, Hashem A, El-Kamary SS, Esmat G, Zakaria S. Zakaria S, et al. Among authors: shaker o. Clin Infect Dis. 2007 Feb 15;44(4):e30-6. doi: 10.1086/511074. Epub 2007 Jan 17. Clin Infect Dis. 2007. PMID: 17243045

3

MxA expression as marker for assessing the therapeutic response in HCV genotype 4 Egyptian patients.

Shaker O, Ahmed A, Doss W, Abdel-Hamid M. Shaker O, et al. J Viral Hepat. 2010 Nov;17(11):794-9. doi: 10.1111/j.1365-2893.2009.01241.x. J Viral Hepat. 2010. PMID: 20002306

4

Genetic variation in BCL-2 and response to interferon in hepatitis C virus type 4 patients.

Shaker OG, Eskander EF, Yahya SM, Mohamed MS, Abd-Rabou AA. Shaker OG, et al. Clin Chim Acta. 2011 Mar 18;412(7-8):593-8. doi: 10.1016/j.cca.2010.12.009. Epub 2010 Dec 13. Clin Chim Acta. 2011. PMID: 21159314

5

Levels of salivary IFN-gamma, TNF-alfa, and TNF receptor-2 as prognostic markers in (erosive) oral lichen planus.

Ghallab NA, el-Wakeel N, Shaker OG. Ghallab NA, et al. Mediators Inflamm. 2010;2010:847632. doi: 10.1155/2010/847632. Epub 2011 Feb 13. Mediators Inflamm. 2010. PMID: 21403886 Free PMC article.

6

Does interferon and ribavirin combination therapy ameliorate growth hormone deficiency in HCV genotype-4 infected patients?

Eskander EF, Abd-Rabou AA, Yahya SM, Shaker OG, Mohamed MS. Eskander EF, et al. Clin Biochem. 2012 Jan;45(1-2):3-6. doi: 10.1016/j.clinbiochem.2011.08.1145. Epub 2011 Sep 12. Clin Biochem. 2012. PMID: 21933670

7

Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.

Abbas E, Shaker O, Abd El Aziz G, Ramadan H, Esmat G. Abbas E, et al. Among authors: shaker o. Eur J Gastroenterol Hepatol. 2012 Apr;24(4):458-63. doi: 10.1097/MEG.0b013e3283508d45. Eur J Gastroenterol Hepatol. 2012. PMID: 22293333

8

Changes in adipocytokines and insulin sensitivity during and after antiviral therapy for hepatitis C genotype 4.

Khattab MA, Eslam M, Shatat M, Abd-Aalhalim H, Mousa YI, Samir F, Aly H, Shaker O, Shaker Y. Khattab MA, et al. Among authors: shaker o, shaker y. J Gastrointestin Liver Dis. 2012 Mar;21(1):59-65. J Gastrointestin Liver Dis. 2012. PMID: 22457861 Free article. Clinical Trial.

9

Single-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C.

Shaker OG, Sadik NA, El-Dessouki A. Shaker OG, et al. Hum Immunol. 2012 Oct;73(10):1039-45. doi: 10.1016/j.humimm.2012.07.329. Epub 2012 Jul 23. Hum Immunol. 2012. PMID: 22836041

10

Polymorphisms in interleukin-10 and interleukin-28B genes in Egyptian patients with chronic hepatitis C virus genotype 4 and their effect on the response to pegylated interferon/ribavirin-therapy.

Shaker OG, Sadik NA. Shaker OG, et al. J Gastroenterol Hepatol. 2012 Dec;27(12):1842-9. doi: 10.1111/j.1440-1746.2012.07273.x. J Gastroenterol Hepatol. 2012. PMID: 23020144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

341 results

Search Page

Filters